Burning Rock Biotech Files 6-K Report
Ticker: BNR · Form: 6-K · Filed: Sep 27, 2024 · CIK: 1792267
Sentiment: neutral
Topics: reporting, foreign-private-issuer
TL;DR
Burning Rock Biotech filed a 6-K, standard reporting for foreign issuers.
AI Summary
Burning Rock Biotech Ltd. filed a Form 6-K on September 27, 2024. This report is for the month of September 2024 and is filed by a foreign private issuer. The company is incorporated in the People's Republic of China and its principal executive offices are located in Guangzhou, Guangdong.
Why It Matters
This filing indicates ongoing reporting requirements for Burning Rock Biotech Ltd. as a foreign private issuer, providing updates to investors.
Risk Assessment
Risk Level: low — A Form 6-K is a routine filing for foreign private issuers and does not typically contain material non-public information that would significantly alter risk.
Key Players & Entities
- Burning Rock Biotech Ltd. (company) — Registrant
- 001-39316 (other) — Commission File Number
- 20240927 (date) — Filing Date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information to the SEC that the company has made or is required to make public in its home country.
What is the filing date of this report?
The filing date of this report is September 27, 2024.
What is the company's principal executive office address?
The company's principal executive offices are located at No.5 Xingdao Ring Road North, International Bio Island, Guangzhou, Guangdong, People's Republic of China.
Does Burning Rock Biotech file annual reports under Form 20-F or Form 40-F?
Burning Rock Biotech indicates it files annual reports under Form 20-F.
What is the Commission File Number for Burning Rock Biotech?
The Commission File Number for Burning Rock Biotech is 001-39316.
Filing Stats: 231 words · 1 min read · ~1 pages · Grade level 13.2 · Accepted 2024-09-27 09:15:26
Filing Documents
- d865934d6k.htm (6-K) — 10KB
- d865934dex991.htm (EX-99.1) — 6KB
- 0001193125-24-227426.txt ( ) — 17KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Burning Rock Biotech Limited By: /s/ Yusheng Han Name: Yusheng Han Title: Chief Executive Officer Date: September 27, 2024 4